K. R. Vagapova
1 ta ish
Polyclinic №1 at the Administrative Department of the President of the Russian Federation, Moscow
Analysis of influence of background therapy for comorbidities in the period before infection on the risk of the lethal COVID outcome. Data from the international ACTIV SARS-CoV-2 registry («Analysis of chronic non-infectious diseases dynamics after COVID-19 infection in adult patients SARS-CoV-2»)
E. I. Tarlovskaya, A. G. Arutyunov, А. О. Конради +97
ABI